Concentrix Corp (CNXC) stock
CNXCNasdaqServices-Business Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 9/3069% below fair value
$30.63−2.04 (-6.24%)
Close on Nov 17, 2026Market cap $1.87BP/E –Yield –
Concentrix EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Concentrix's EPS for the twelve months ending Aug 31, 2026 was -$38.85, down 921.4% year over year. For fiscal 2025 it was -$20.36, down 648.8% from the year before. The highest annual figure on record is $8.28 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | -$20.36 | -648.8% |
| FY2024 | Nov 30, 2024 | $3.71 | -34.9% |
| FY2023 | Nov 30, 2023 | $5.70 | -31.2% |
| FY2022 | Nov 30, 2022 | $8.28 | +7.5% |
| FY2021 | Nov 30, 2021 | $7.70 | +141.4% |
| FY2020 | Nov 30, 2020 | $3.19 | +40.5% |
| FY2019 | Nov 30, 2019 | $2.27 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | -$16.24 | -1311.9% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $0.86 | +36.5% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $0.33 | -68.3% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | -$23.80 | -1483.7% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $1.34 | +436.0% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $0.63 | -35.7% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $1.04 | +36.8% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $1.72 | +57.8% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $0.25 | -83.2% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $0.98 | -35.1% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $0.76 | -54.8% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $1.09 | -45.5% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $1.49 | -27.0% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $1.51 | -29.4% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $1.68 | -19.6% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $2.00 | -15.3% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $2.04 | -1.9% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $2.14 | +36.3% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $2.09 | +23.7% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | $2.36 | +88.8% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $2.08 | +136.4% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $1.57 | +3040.0% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $1.69 | +67.3% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $1.25 | – |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $0.88 | – |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $0.05 | – |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $1.01 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?